The ongoing study could significantly impact the stock performance of Regeneron and Sanofi, as successful results may enhance their market position and investor confidence. The development of ...

In a study known as CROWNS-2 published in JAMA, the researchers randomly assigned 180 adults with CRSwNP to stapokibart (300 ...

Anabelle Terry, a slender, self-possessed 13-year-old, has heard the peanut butter story her entire life. A visit to an ...

For severe chronic rhinosinusitis with nasal polyps, novel stapokibart reduced symptoms and polyp size atop treatment with a ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Terns Pharmaceuticals is planning to stop inve | Terns Pharmaceuticals is planning to stop investing in metabolic disease clinical development at the end of 2025, starting a countdown to potential ...

Nebraska Medicine is testing a new multiple sclerosis treatment for the first time in the world.

Erika's number is up. The post RHOBH’s Erika Jayne Headed to Trial Over $25 Million Spendings: Here’s What We Know appeared first on Reality Tea.

The FDA has issued another Complete Response Letter to Regeneron for odronextamab in relapsed/refractory follicular lymphoma.

Follow live results from 2025 All American Futurity trials. Sixteen races Monday and 16 Tuesday. Post time is 11 a.m. both days.

Regeneron Pharmaceuticals (REGN 2.46%) is getting a thumbs-up from Wall Street, with some analysts predicting potential upside over the next 12 months in the ballpark of 29% at the midpoint, or up ...

Check out our roundups below for the best free trials, discounts, and deals for students. Free Trials and Discounts on Services for Students 3 months free ...